epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Adrenaclick
    epinephrine (adrenaline)
  • remove Edarbi
    azilsartan medoxomil
  • remove Levsin
    hyoscyamine

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Adrenaclick (epinephrine (adrenaline)) + Edarbi (azilsartan medoxomil)

Monitor/Modify Tx


epinephrine + azilsartan medoxomil

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face Adrenaclick (epinephrine (adrenaline)) + Levsin (hyoscyamine)

Monitor/Modify Tx


epinephrine + hyoscyamine

monitor HR: combo may incr. risk of tachycardia (additive effects)

Additional Considerations

Smiley face Smiley face epinephrine in Adrenaclick

nasal epinephrine use: caution advised with nasal drugs, including subsequent nasal epinephrine doses, up to 2 wk after initial administration; nasal epinephrine may incr. systemic absorption of nasal drugs, risk of adverse effects

Smiley face Smiley face hyoscyamine in Levsin

caution advised with concurrent oral drugs requiring rapid onset; hyoscyamine delays gastric emptying, may alter absorption of concomitant oral drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information